MAPK13 and breast carcinoma: qPCR analysis further validated MAPK13 induction upon rapamycin treatment in several mTORC1-overactive cells including UMB1949, MCF7 (PI3K-mutated breast cancer) (32), and BT549 (PTEN-deficient breast cancer) (33) (Fig. 1, G–I).